Veterinary Medicines

Prazpronto 40mg Spot-on Solution for Medium Cats

Not authorised
  • Praziquantel
Download as PDF

Product identification

Medicine name:
Prazpronto 40 mg Spot-on solution for medium cats
Prazpronto 40mg Spot-on Solution for Medium Cats
Active substance:
  • Praziquantel
Target species:
  • Cat
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Praziquantel
    40.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA01
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Expired
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 1 pipette in individual foil sachets.
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 2 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 3 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 4 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 6 pipettes in individual foil sachets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 08749/4091
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0633/002

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."